Infinite Reality Acquires the Drone Racing League for $250 Million, Solidifying Position as Global Leader in Immersive Technology & Experiences
April 23, 2024 07:05 ET
|
Infinite Reality Inc.
Watch the teaser video NEW YORK, April 23, 2024 (GLOBE NEWSWIRE) -- In a landmark deal to enhance its immersive platform technology and services, Infinite Reality (“iR” or the “Company”), a...
Manhattan Bridge Capital, Inc. Reports First Quarter Results for 2024
April 23, 2024 07:05 ET
|
Manhattan Bridge Capital, Inc.
GREAT NECK, N.Y., April 23, 2024 (GLOBE NEWSWIRE) -- Manhattan Bridge Capital, Inc. (Nasdaq: LOAN) announced today that its net income for the three months ended March 31, 2024...
Lantronix to Participate in the 21st Annual Craig-Hallum Institutional Investor Conference on May 29, 2024
April 23, 2024 07:02 ET
|
Lantronix, Inc.
Lantronix to Participate in the 21st Annual Craig-Hallum Institutional Investor Conference on May 29, 2024
Global Next Generation Non Volatile Memory Business Report 2024: Market to Reach $37.3 Billion by 2030 - Critical Role of Non-volatile Memory in Smart City Applications Bodes well for the Sector
April 23, 2024 07:01 ET
|
Research and Markets
Dublin, April 23, 2024 (GLOBE NEWSWIRE) -- The "Next Generation Non Volatile Memory - Global Strategic Business Report" report has been added to ResearchAndMarkets.com's offering.Global Next...
Apellis Pharmaceuticals to Host Conference Call on May 7, 2024, to Discuss First Quarter 2024 Financial Results
April 23, 2024 07:00 ET
|
Apellis Pharmaceuticals, Inc.
WALTHAM, Mass., April 23, 2024 (GLOBE NEWSWIRE) -- Apellis Pharmaceuticals, Inc. (Nasdaq: APLS) today announced that the company will host a conference call and webcast to discuss its first quarter...
Dimensional Fund Advisors Ltd. : Form 8.3 - DS SMITH PLC - Ordinary Shares
April 23, 2024 07:00 ET
|
Dimensional Fund Advisors Ltd
FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BYA PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORERule 8.3 of the Takeover Code (the “Code”) 1.KEY...
Omega Therapeutics to Present New Preclinical Data on Epigenomic Upregulation at the American Society of Gene and Cell Therapy 27th Annual Meeting
April 23, 2024 07:00 ET
|
Omega Therapeutics
CAMBRIDGE, Mass., April 23, 2024 (GLOBE NEWSWIRE) -- Omega Therapeutics, Inc. (Nasdaq: OMGA) (“Omega”), a clinical-stage biotechnology company pioneering the development of a new class of...
Regeneration Biomedical Doses First Patient in a First-in-Human Phase I Clinical Trial of Stem Cell Therapy delivered directly into the brain of Patients with Alzheimer’s Disease
April 23, 2024 07:00 ET
|
Regeneration Biomedical, Inc.
NEWPORT BEACH, Calif., April 23, 2024 (GLOBE NEWSWIRE) -- Regeneration Biomedical, Inc. (“RBI”), a clinical-stage company developing autologous stem cell treatments for neurodegenerative diseases,...
Arhasi’s Confidentiality Concierge redefines AI Chatbot Security
April 23, 2024 07:00 ET
|
Arhasi
Frisco, TX, April 23, 2024 (GLOBE NEWSWIRE) -- Arhasi, a boutique startup leading in AI security, governance, and compliance, introduced today its groundbreaking Confidentiality Concierge service....
ProQR Nominates Martin Maier, PhD to Board and Announces Annual Meeting of Shareholders to be Held May 22, 2024
April 23, 2024 07:00 ET
|
ProQR Therapeutics N.V.
LEIDEN, Netherlands & CAMBRIDGE, Mass., April 23, 2024 (GLOBE NEWSWIRE) -- ProQR Therapeutics NV. (Nasdaq: PRQR) (ProQR), a company dedicated to changing lives through transformative RNA...